China Pharma Holdings (CPHI) Work In Process: 2017-2024
Historic Work In Process for China Pharma Holdings (CPHI) over the last 7 years, with Sep 2024 value amounting to $334,430.
- China Pharma Holdings' Work In Process fell 50.59% to $334,430 in Q3 2024 from the same period last year, while for Sep 2024 it was $334,430, marking a year-over-year decrease of 50.59%. This contributed to the annual value of $413,597 for FY2023, which is 25.77% down from last year.
- Per China Pharma Holdings' latest filing, its Work In Process stood at $334,430 for Q3 2024, which was up 283.05% from $87,308 recorded in Q2 2024.
- Over the past 5 years, China Pharma Holdings' Work In Process peaked at $676,885 during Q3 2023, and registered a low of $87,308 during Q2 2024.
- In the last 3 years, China Pharma Holdings' Work In Process had a median value of $360,808 in 2022 and averaged $396,779.
- Its Work In Process has fluctuated over the past 5 years, first soared by 110.99% in 2020, then crashed by 76.07% in 2024.
- Over the past 5 years, China Pharma Holdings' Work In Process (Quarterly) stood at $662,999 in 2020, then decreased by 15.97% to $557,146 in 2021, then remained steady at $557,146 in 2022, then dropped by 25.77% to $413,597 in 2023, then crashed by 50.59% to $334,430 in 2024.
- Its Work In Process stands at $334,430 for Q3 2024, versus $87,308 for Q2 2024 and $242,726 for Q1 2024.